UNSPSC 51352302: Cloxestradiol

This classification denotes a therapeutic estrogen with the molecular formula C20H25Cl3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42R9MZG1DL, chemically known as 17 beta-(2,2,2-trichloro-1-hydroxyethoxy)estra-1,3,5(10)-trien-3-ol. but generally known as cloxestradiol, which bears US NIH Compound Identifier 194705. European Medicines Agency schedules Cloxestradiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06782MIG. The term CLOXESTRADIOL is an International Non-Proprietary Name.

UNSPSC 51352302 Cloxestradiol is a Commodity code covering pharmaceutical products supplied through state and local cooperative purchasing agreements. State and local governments procure cloxestradiol and related generic pharmaceuticals as part of broader multi-source drug procurement vehicles that distribute products across state agencies, local government facilities, school districts, and healthcare institutions. The work involves establishing supply contracts with manufacturers who meet cGMP certification, Drug Supply Chain Security Act compliance, FDA approval, and wholesaler integration requirements, with pricing structured through authorized distributor networks and subject to administrative fees and performance penalties for contract compliance.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026, to establish multiple-award contracts for generic pharmaceuticals and OTC products with proposals due March 26, 2026. MMCAP's procurement spans participating state and local government facilities across Minnesota, Oregon, and other consortium members, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and maintain inventory with minimum one-year expiration dates and six-month shelf life. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and 5 percent each on administrative compliance, EDI capability, and acceptance of the 3 percent administrative fee. Awarded vendors face performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials, with contract terms of two years for new responders and optional extensions at MMCAP's discretion.